Horizon Pharma Company Profile (NASDAQ:HZNP)

About Horizon Pharma

Horizon Pharma logoHorizon Pharma plc, formerly Vidara Therapeutics International Public Limited Company, is a biopharmaceutical company. The Company is focused on identifying, developing, acquiring or in-licensing and commercializing differentiated products. It markets approximately nine medicines through its orphan, primary care and rheumatology business units. Its segment focuses on the identification, development, acquisition and commercialization of differentiated and accessible medicines. Its marketed medicines include ACTIMMUNE (interferon gamma-1b), BUPHENYL (sodium phenylbutyrate) Tablets and Powder, DUEXIS (ibuprofen/famotidine), KRYSTEXXA (pegloticase), MIGERGOT (ergotamine tartrate and caffeine suppositories), PENNSAID (diclofenac sodium topical solution) 2% w/w, or PENNSAID 2%, RAVICTI (glycerol phenylbutyrate) Oral Liquid, RAYOS (prednisone) delayed-release tablets and VIMOVO (naproxen/esomeprazole magnesium). It also developed DUEXIS and RAYOS, known as LODOTRA.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: HZNP
  • CUSIP: 44047T10
Key Metrics:
  • Previous Close: $17.77
  • 50 Day Moving Average: $19.86
  • 200 Day Moving Average: $17.66
  • 52-Week Range: $12.86 - $23.70
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 6.68
  • P/E Growth: 0.46
  • Market Cap: $2.87B
  • Outstanding Shares: 160,904,000
  • Beta: 1.9
Profitability:
  • Net Margins: -0.34%
  • Return on Equity: 23.46%
  • Return on Assets: 9.76%
Debt:
  • Debt-to-Equity Ratio: 0.85%
  • Current Ratio: 2.24%
  • Quick Ratio: 1.83%
Additional Links:
Companies Related to Horizon Pharma:

Analyst Ratings

Consensus Ratings for Horizon Pharma (NASDAQ:HZNP) (?)
Ratings Breakdown: 2 Hold Ratings, 11 Buy Ratings
Consensus Rating:Buy (Score: 2.85)
Consensus Price Target: $31.27 (75.99% upside)

Analysts' Ratings History for Horizon Pharma (NASDAQ:HZNP)
Show:
DateFirmActionRatingPrice TargetDetails
9/29/2016MizuhoReiterated RatingBuyView Rating Details
9/28/2016Morgan StanleyReiterated RatingHold$24.00View Rating Details
9/27/2016Goldman Sachs Group Inc.Reiterated RatingBuy$27.00View Rating Details
9/13/2016BMO Capital MarketsReiterated RatingOutperform$30.00View Rating Details
9/12/2016Brean CapitalReiterated RatingBuy$32.00View Rating Details
9/12/2016Cowen and CompanyReiterated RatingOutperform -> Outperform$42.00View Rating Details
9/8/2016Jefferies GroupReiterated RatingBuyView Rating Details
8/23/2016GuggenheimReiterated RatingBuy$30.00View Rating Details
8/10/2016Piper Jaffray Cos.Reiterated RatingOverweight$34.00 -> $33.00View Rating Details
8/9/2016Citigroup Inc.Boost Price TargetNeutral$18.00 -> $21.00View Rating Details
7/6/2016Stifel NicolausReiterated RatingBuy$45.00View Rating Details
11/11/2015WallachBeth CapitalUpgradeBuyView Rating Details
10/22/2015JMP SecuritiesReiterated RatingBuyView Rating Details
7/7/2015Leerink SwannReiterated RatingPositive$37.00View Rating Details
(Data available from 9/30/2014 forward)

Earnings

Earnings History for Horizon Pharma (NASDAQ:HZNP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2016        
8/8/2016Q216$0.50$0.62$235.43 million$257.40 millionViewN/AView Earnings Details
5/9/2016Q116$0.30$0.34$197.73 million$204.70 millionViewN/AView Earnings Details
2/29/2016Q415$0.62$0.63$240.92 million$244.50 millionViewListenView Earnings Details
11/6/2015Q315$0.40$0.70$185.70 million$292.70 millionViewListenView Earnings Details
8/7/2015Q215$0.32$0.39$156.41 million$172.80 millionViewListenView Earnings Details
5/8/2015Q115$0.21$0.21$104.20 million$113.10 millionViewN/AView Earnings Details
2/27/2015Q414$0.23$0.27$95.50 million$103.80 millionViewN/AView Earnings Details
11/6/2014Q314$0.17$0.24$73.17 million$75.10 millionViewN/AView Earnings Details
8/7/2014Q214$0.10$0.21$58.35 million$66.10 millionViewN/AView Earnings Details
5/9/2014Q114$0.01$0.16$42.69 million$51.90 millionViewN/AView Earnings Details
3/13/2014Q413($0.08)($0.22)$32.20 million$43.10 millionViewN/AView Earnings Details
11/8/2013Q3 13($0.25)($0.03)$18.31 million$31.50 millionViewN/AView Earnings Details
8/9/2013Q213($0.32)($0.24)$16.09 million$17.64 millionViewN/AView Earnings Details
5/10/2013Q113($0.35)($0.30)$9.47 million$9.20 millionViewN/AView Earnings Details
11/13/2012Q312($0.68)($0.39)$4.12 million$7.20 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Horizon Pharma (NASDAQ:HZNP)
Current Year EPS Consensus Estimate: $1.82 EPS
Next Year EPS Consensus Estimate: $2.66 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.58$0.58$0.58
Q2 20161$0.49$0.49$0.49
Q3 20161$0.66$0.66$0.66
Q4 20161$0.68$0.68$0.68
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Horizon Pharma (NASDAQ:HZNP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Horizon Pharma (NASDAQ:HZNP)
Insider Ownership Percentage: 2.10%
Institutional Ownership Percentage: 85.25%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/2/2016Jeffrey W. ShermanEVPSell2,900$20.00$58,000.00View SEC Filing  
6/15/2016Virinder NohriaDirectorSell25,000$17.69$442,250.00View SEC Filing  
2/26/2016Jeffrey W ShermanEVPSell4,100$20.00$82,000.00View SEC Filing  
12/10/2015Jeffrey W ShermanEVPSell4,456$20.00$89,120.00View SEC Filing  
9/21/2015Jeffrey W ShermanEVPSell7,750$31.78$246,295.00View SEC Filing  
7/15/2015Jeffrey W ShermanEVPSell26,887$35.55$955,832.85View SEC Filing  
3/13/2015Jeff HimawanDirectorSell554,564$22.44$12,444,416.16View SEC Filing  
3/10/2015Jeff HimawanDirectorSell1,614,827$21.85$35,283,969.95View SEC Filing  
11/19/2014Jeff HimawanDirectorSell3,450,000$12.05$41,572,500.00View SEC Filing  
11/19/2014Jeffrey W ShermanEVPSell24,999$12.05$301,237.95View SEC Filing  
11/19/2014Timothy P WalbertCEOSell150,000$12.05$1,807,500.00View SEC Filing  
11/13/2014Balaji VenkataramanMajor ShareholderSell6,086,957$11.54$70,243,483.78View SEC Filing  
11/13/2014Virinder NohriaDirectorSell1,739,130$11.54$20,069,560.20View SEC Filing  
9/30/2014Vaere Robert J DeCFOSell51,942$12.28$637,847.76View SEC Filing  
5/19/2014Timothy WalbertCEOSell31,742$12.94$410,741.48View SEC Filing  
5/19/2014Todd SmithEVPSell10,159$12.94$131,457.46View SEC Filing  
5/19/2014Vaere Robert DeCFOSell12,939$12.94$167,430.66View SEC Filing  
12/13/2013Jeffrey BirdDirectorBuy668,673$6.50$4,346,374.50View SEC Filing  
12/9/2013Timothy WalbertCEOSell12,124$6.79$82,321.96View SEC Filing  
12/9/2013Todd SmithEVPSell11,322$6.91$78,235.02View SEC Filing  
11/21/2013Jeffrey BirdDirectorBuy151,089$6.24$942,795.36View SEC Filing  
9/25/2012Jeffrey W BirdDirectorBuy575,356$3.49$2,007,992.44View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Horizon Pharma (NASDAQ:HZNP)
DateHeadline
streetinsider.com logoHorizon Pharma (HZNP) Enters Settlement agreement with Express Scripts (ESRX); Will Pay $65M (NASDAQ:HZNP)
www.streetinsider.com - September 29 at 10:36 AM
marketrealist.com logoWhy Horizon Trades at a Discount Compared to Its Peers (NASDAQ:HZNP)
marketrealist.com - September 22 at 8:40 AM
marketrealist.com logoNews of Acquisition Caused Horizon Pharma Stock to Rise - Market ... - Market Realist (NASDAQ:HZNP)
marketrealist.com - September 21 at 3:46 PM
marketrealist.com logoHow Analysts See Horizon Compared to Its Peers (NASDAQ:HZNP)
marketrealist.com - September 21 at 3:46 PM
thestreet.com logoHorizon Pharma Is Stuck Going Sideways (NASDAQ:HZNP)
realmoney.thestreet.com - September 21 at 3:46 PM
News IconStock Recent Trading Summary: Horizon Pharma plc (NASDAQ:HZNP) (NASDAQ:HZNP)
magseriesusa.net - September 21 at 9:43 AM
News IconAnalysts showing optimistic trends for: Horizon Pharma plc (NASDAQ:HZNP) (NASDAQ:HZNP)
thelakeandeswave.com - September 21 at 9:43 AM
News IconAnalyst Price Target Review: Horizon Pharma plc (NASDAQ:HZNP) (NASDAQ:HZNP)
www.crcconnection.com - September 21 at 9:43 AM
marketrealist.com logoProcysbi: Major Addition to Horizon’s Orphan Drug Portfolio (NASDAQ:HZNP)
marketrealist.com - September 21 at 9:43 AM
marketrealist.com logoHow the Numbers Add Up for the Horizon Pharma–Raptor Deal (NASDAQ:HZNP)
marketrealist.com - September 20 at 10:39 AM
marketexclusive.com logoDepomed Inc (NASDAQ:DEPO): Here’s What You Need To Know (NASDAQ:HZNP)
marketexclusive.com - September 19 at 5:36 PM
News IconDublin based Horizon to buy Raptor for $800m (NASDAQ:HZNP)
www.crcconnection.com - September 15 at 5:54 PM
News IconStocks Getting Stung by Investment Assessment: Horizon Pharma ... - Street Wise Report (press release) (blog) (NASDAQ:HZNP)
streetwisereport.com - September 15 at 8:40 AM
thestreet.com logoHorizon Pharma (HZNP) Stock Price Target Increased at Brean Capital (NASDAQ:HZNP)
www.thestreet.com - September 14 at 9:46 AM
thestreet.com logoMore Rare Disease Dealmaking to Follow Horizon's Raptor Deal (NASDAQ:HZNP)
www.thestreet.com - September 14 at 9:46 AM
finance.yahoo.com logoHorizon (HZNP) to Acquire Raptor for $800M, Stock Soars (NASDAQ:HZNP)
finance.yahoo.com - September 14 at 9:46 AM
biz.yahoo.com logoHORIZON PHARMA PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits (NASDAQ:HZNP)
biz.yahoo.com - September 14 at 9:46 AM
finance.yahoo.com logoBiotech Stock Roundup: Horizon-Raptor Acquisition Deal, Geron Down on Pipeline News (NASDAQ:HZNP)
finance.yahoo.com - September 14 at 9:46 AM
News IconBlog Coverage Horizon Pharma Strengthens its Position in Rare Diseases with Raptor Pharma Acquisition (NASDAQ:HZNP)
news.investornetwork.com - September 13 at 10:20 AM
News IconHorizon Pharma plc to Acquire Raptor Pharmaceutical Corp. as Further Step in Building Leading Rare Disease Business (NASDAQ:HZNP)
www.econotimes.com - September 12 at 5:24 PM
streetinsider.com logoHorizon Pharma plc (HZNP) to Acquire Raptor Pharmaceutical (RPTP) for $800M (NASDAQ:HZNP)
www.streetinsider.com - September 12 at 5:24 PM
feeds.reuters.com logoRPT-UPDATE 2-Horizon Pharma to buy Raptor Pharma for $800 mln (NASDAQ:HZNP)
feeds.reuters.com - September 12 at 11:52 AM
feeds.reuters.com logoUPDATE 2-Horizon Pharma to buy Raptor Pharma for $800 mln (NASDAQ:HZNP)
feeds.reuters.com - September 12 at 10:33 AM
benzinga.com logoRaptor Jumps 20% After Horizon Pharma's $800 Million Takeover Agreement - Benzinga (NASDAQ:HZNP)
www.benzinga.com - September 12 at 10:15 AM
finance.yahoo.com logoHorizon Pharma to buy Raptor Pharma for $800 mln (NASDAQ:HZNP)
finance.yahoo.com - September 12 at 10:15 AM
News IconWhy Horizon Pharma Is Not Overpaying for Raptor Pharma (NASDAQ:HZNP)
feedproxy.google.com - September 12 at 9:31 AM
seekingalpha.com logoHorizon Pharma takes out Raptor Pharma for $800M (NASDAQ:HZNP)
seekingalpha.com - September 12 at 8:32 AM
feeds.benzinga.com logoRaptor Jumps 20% After Horizon Pharma's $800 Million Takeover Agreement (NASDAQ:HZNP)
feeds.benzinga.com - September 12 at 8:32 AM
biz.yahoo.com logoHORIZON PHARMA PLC Files SEC form 8-K, Entry into a Material Definitive Agreement (NASDAQ:HZNP)
biz.yahoo.com - September 8 at 5:26 PM
News IconHC Stocks Alerts: Horizon Pharma PLC (HZNP), Brookdale Senior Living, Inc. (NYSE:BKD) - share market updates (press release) (NASDAQ:HZNP)
sharemarketupdates.com - September 7 at 5:41 PM
benzinga.com logoHorizon Pharma An Attractive Sum-Of-The-Parts Story, Says Goldman - Benzinga (NASDAQ:HZNP)
www.benzinga.com - September 7 at 5:41 PM
wsj.com logo[$$] New Back-Office Tech Can Be a Merger’s Best Friend (NASDAQ:HZNP)
www.wsj.com - September 6 at 10:18 AM
finance.yahoo.com logoHorizon Pharma plc to Participate in Morgan Stanley Global Healthcare Conference (NASDAQ:HZNP)
finance.yahoo.com - September 6 at 10:18 AM
wsj.com logo[$$] New Back-Office Tech Can Be a Merger's Best Friend (NASDAQ:HZNP)
www.wsj.com - September 5 at 5:01 PM
thestreet.com logoHorizon Pharma (HZNP) Stock Stumbles, Could Be at Risk from Clinton Drug Plan (NASDAQ:HZNP)
www.thestreet.com - September 2 at 5:29 PM
prnewswire.com logoGeneric Drugs Stocks Technical Reports -- Mylan, Horizon Pharma, Allergan, and Akorn (NASDAQ:HZNP)
www.prnewswire.com - September 2 at 10:23 AM
publicnow.com logoNuvo Pharmaceuticals™ Inc. Appoints New Chief Financial Officer (NASDAQ:HZNP)
www.publicnow.com - September 1 at 5:26 PM
capitalcube.com logoHorizon Pharma Plc breached its 50 day moving average in a Bearish Manner : HZNP-US : August 26, 2016 (NASDAQ:HZNP)
www.capitalcube.com - August 26 at 8:32 AM
capitalcube.com logoETF’s with exposure to Horizon Pharma Plc : August 25, 2016 (NASDAQ:HZNP)
www.capitalcube.com - August 25 at 10:33 AM
feeds.benzinga.com logoWatch These 7 Huge Call Purchases In Thursday Trade (NASDAQ:HZNP)
feeds.benzinga.com - August 25 at 3:22 AM
News IconGuggenheim Reiterates Buy at Horizon Pharma Inc. (NASDAQ: HZNP) - BNB Daily (blog) (NASDAQ:HZNP)
www.baseball-news-blog.com - August 24 at 8:39 AM
marketrealist.com logoThe Word on the Street: How Do Analysts See Horizon Pharma? (NASDAQ:HZNP)
marketrealist.com - August 22 at 5:37 PM
News IconHORIZON PHARMA IRELAND LIMITED v. ACTAVIS LABORATORIES, UT, INC. (NASDAQ:HZNP)
www.leagle.com - August 19 at 8:31 AM
globenewswire.com logoHorizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of ... (NASDAQ:HZNP)
globenewswire.com - August 18 at 8:35 AM
finance.yahoo.com logo7:03 am Horizon Pharma announces that the USPTO has granted a NOA for a patent that covers its RAYOS (prednisone) delayed-release tablets (NASDAQ:HZNP)
finance.yahoo.com - August 18 at 8:35 AM
publicnow.com logoHorizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering RAYOS® (prednisone) Delayed-Release Tablets (NASDAQ:HZNP)
www.publicnow.com - August 18 at 8:35 AM
finance.yahoo.com logoHORIZON PHARMA PLC Financials (NASDAQ:HZNP)
finance.yahoo.com - August 13 at 5:23 PM
capitalcube.com logoETF’s with exposure to Horizon Pharma Plc : August 12, 2016 (NASDAQ:HZNP)
www.capitalcube.com - August 12 at 5:37 PM
capitalcube.com logoHorizon Pharma Plc :HZNP-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016 (NASDAQ:HZNP)
www.capitalcube.com - August 11 at 5:46 PM
finance.yahoo.com logoNuvo Pharmaceuticals™ Announces 2016 Second Quarter Results (NASDAQ:HZNP)
finance.yahoo.com - August 10 at 5:50 PM

Social

Horizon Pharma (NASDAQ:HZNP) Chart for Friday, September, 30, 2016


Last Updated on 9/30/2016 by MarketBeat.com Staff